EULAR Corporate members

EULAR is set up of four types of institutional members: scientific societies, national organisations of people with arthritis/rheumatism and health professionals as well as corporate members.

 

AbbVie

AMGEN

AstraZeneca

Biogen International GmbH

Boehringer Ingelheim Pharma GmbH & Co. KG

Bristol-Myers Squibb UPSA

Celltrion Healthcare Co. Ltd.

FRESENIUS KABI SWISSBIOSIM

Galapagos

Gilead Sciences

GlaxoSmithKline

Grünenthal GmbH

Hoffmann-La Roche Ltd.

IBSA Institut Biochimique SA

Janssen

Lilly

medac GmbH

MENARINI FARMACEUTICA INTERNAZIONALE

Novartis Pharma AG

Pfizer Pharmaceutical Group

Samsung Bioepis

Sanofi Genzyme

TRB Chemedica International SA

UCB PHARMA SA

Vifor Fresenius Medical Care Renal Pharma Ltd.

Related Information

The EULAR Family

A presentation of the EULAR member organisations.

See more


EULAR Governance

EULAR is governed by an elected board composed by 4 experts in rheumatology and one representative of each pillar (organisations representing other health professionals in rheumatology, patient organisations and scientific societies). Our activities are overseen by 5 content committees and 4 representation committees whose activities are delivered by several hundred expert rheumatology volunteers.

See more


EULAR Communities

EULAR underscores the importance of combating rheumatic diseases not only by medical means, but also through a wider context of care for rheumatic patients and a thorough understanding of their social and other needs. 

EULAR comprises the HPR, PARE and EMEUNET communities, which include 105 member societies / organisations, working on a variety of activities supporting EULAR objectives.

See more